Cardiac electrophysiological effects of levosimendan, a new calcium sensitizer

General Pharmacology

Volumn 27, Issue 3, 1996, Pages 551-556

  Virág, László ^a   Hála, Ottó ^a   Marton, Anita ^a   Varró, András ^a   Papp, Julius Gy ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Calcium current; Calcium sensitizer; Electrophysiology; Levosimendan; Potassium currents

Indexed keywords

CALCIUM SENSITIZER; LEVOSIMENDAN; PHOSPHODIESTERASE INHIBITOR;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GUINEA PIG; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART VENTRICLE WALL; MALE; MUSCLE TWITCH; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; RABBIT;

EID: 0342561598     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)02060-8     Document Type: Article

References (21)

1. Armstrong P. W. and Moe D. W. (1994) Medical advances in the treatment of congestive heart failure. Circulation 88, 2941-2952.
2. Attwell D., Cohen I., Eisner D., Ohba M. and Ojeda C. (1979) The steady-state TTX-sensitive ("window") sodium current in cardiac Purkije fibers. Pflügers Arch. 379, 137-142.
3. Belles B., Malecot C. O., Hescheler J. and Trautwein W. (1988) "Run-down" of the Ca current during long whole-cell recordings in guinea pig heart cells: role of phosphorylation and intracellular calcium. Pflügers Arch. 411, 353-360.
4. Bers D. M., editor (1991) Excitation-contraction coupling and contractile force. Kluwer Academic Publishers, Dordrecht, Boston, London.
5. Buggisch D., Isenberg G., Ravens U. and Scholtysik G. (1985) The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparations. Em. J. Pharmac. 118, 303-311.
6. 2+ sensitivity, sarcoplasmic reticular (SR) function and phosphorylation. Circulation 90, 1-217.
7. 2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ. Res. 77, 107-113.
8. Haikala H., Nissinen E., Etemadzedeh E., Linden I.-B. and Pohto P. (1992) Levosimendan increases calcium sensitivity without enhancing myosin ATPase activity and impairing relaxation. J. Mol. Cell. Cardiol. 24 (Supplement V), S. 97.
9. 2+ window current in heart cells. Circ. Res. 70, 445-455.
10. Hoffmann B. F. and Bigger B. T. (1985) Digitalis and allied glycosides. In The Pharmacological Basis of Therapeutics, 7th ed., pp. 716-48. (Edited by Goodman L. S. and Gilman A.) MacMillan, New York.
11. Iijima T. and Taira N. (1987) Membrane current changes responsible for the positive inotropic effect of OPC-8212, a new positive inotropic agent, in single ventricular cells of the guinea pig heart. J. Pharmac. Exp. Ther. 240, 657-662.
12. Lathrop D. A., Nánási P. P., Schwartz A. and Varró A. (1993) Ionic basis for OPC-8212 induced increase in action potential duration in isolated rabbit, guinea pig and human ventricular myocytes. Em. J. Pharmac. 240, 127-137.
13. Morad M. and Trautwein W. (1968) The effect of the duration of the action potential on contraction in the mammalian heart muscle. Pflügers Arch. 299, 66-82.
14. Lilleberg J., Antila S., Karlsson M., Nieminen M. S. and Pentkainen P. J. (1994) Pharmacokinetics and pharmacodynamics of simendan, a novel calcium sensitizer, in healthy volunteers. Clin. Pharmac. Ther. 56, 554-563.
15. Pagel P. S., Harkin C. P., Hettrick D. A., Warltier D. C. (1994) Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractil-ity but does not alter isovolumic relaxation in conscious and anesthetized dogs. Anesthesiology 81, 974-987.
16. 2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. J. Biol. Chem. 269, 28584-28590.
17. Raasmaja A., Talo A., Haikala H., Nissinen E., Linden I. B. and Pohto P. (1992) Biochemical properties of OR-1259 a positive inotropic and vasodilatory compound with an antiarrhythmic effect. Adv. Exp. Med. Biol. 311, 423.
18. Rump A. F. E., Acar D. and Klaus W. (1994a) A quantitative comparison of functional and anti-ischemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. Br. J. Pharmac. 112, 757-762.
19. Rump A. F. E., Acar D., Rosen R., Klaus W. (1994b) Functional and antiischaemic effects of the phosphodiesterase inhibitor levosimendan in isolated rabbit hearts. Pharmac. Toxicol. 74, 244-248.
20. Scholtysik G., Salzmann R., Berthold R., Herzig J. W., Quast U. and Markestein R. (1985) DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties. Naunyn-Schmiedeberg's Arch. Pharmac. 329, 316-325.
21. max in K-depolarized guinea pig ventricle: Effects of nifedipine and verapamil. J. Cardiovasc, Pharmac. 7, 197-204.